Intech Investment Management LLC Incyte Corp Transaction History

Intech Investment Management LLC

$10.2 Billion
Q2 2025

A detailed history of Intech Investment Management LLC transactions in Incyte Corp stock. As of the latest transaction made, Intech Investment Management LLC holds 69,779 shares of INCY stock, worth $5.91 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

69,779

Previous 33,308 109.5%

Holding current value

$5.91 Million

Previous $2.02 Million 135.66%

% of portfolio

0.05%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	BUY	$55.17 - $71.22 $2.01 Million - $2.6 Million	36,471 Added 109.5%	69,779 $4.75 Million
Q1 2025 May 20, 2025	BUY	$60.0 - $75.26 $256,800 - $322,112	4,280 Added 14.74%	33,308 $2.02 Million
Q4 2024 Feb 10, 2025	SELL	$65.08 - $83.38 $2.16 Million - $2.77 Million	-33,228 Reduced 53.37%	29,028 $2 Million
Q3 2024 Nov 08, 2024	SELL	$57.33 - $68.61 $2.52 Million - $3.01 Million	-43,897 Reduced 41.35%	62,256 $4.12 Million
Q2 2024 Aug 12, 2024	BUY	$51.18 - $63.75 $2.76 Million - $3.44 Million	53,886 Added 103.1%	106,153 $6.43 Million
Q1 2024 May 10, 2024	SELL	$56.55 - $66.59 $2 Million - $2.36 Million	-35,411 Reduced 40.39%	52,267 $2.98 Million
Q4 2023 Oct 18, 2024	SELL	$52.16 - $64.19 $2.12 Million - $2.61 Million	-40,728 Reduced 31.72%	87,678 $5.51 Million
Q4 2023 Feb 09, 2024	SELL	$52.16 - $64.19 $2.12 Million - $2.61 Million	-40,728 Reduced 31.72%	87,678 $5.51 Million
Q3 2023 Oct 18, 2024	SELL	$57.77 - $65.93 $5.94 Million - $6.77 Million	-102,737 Reduced 44.45%	128,406 $7.42 Million
Q3 2023 Nov 13, 2023	SELL	$57.77 - $65.93 $6.14 Million - $7.01 Million	-106,277 Reduced 45.29%	128,406 $7.42 Million
Q2 2023 Oct 18, 2024	SELL	$60.95 - $75.51 $809,537 - $1 Million	-13,282 Reduced 5.43%	231,143 $14.4 Million
Q2 2023 Aug 09, 2023	SELL	$60.95 - $75.51 $1.01 Million - $1.25 Million	-16,563 Reduced 6.59%	234,683 $14.6 Million
Q1 2023 Oct 18, 2024	BUY	$70.23 - $86.01 $9.71 Million - $11.9 Million	138,272 Added 130.26%	244,425 $17.7 Million
Q1 2023 May 10, 2023	BUY	$70.23 - $86.01 $5.37 Million - $6.57 Million	76,400 Added 43.7%	251,246 $18.2 Million
Q4 2022 Oct 18, 2024	BUY	$67.18 - $84.11 $4.48 Million - $5.61 Million	66,752 Added 65.2%	169,131 $13.6 Million
Q4 2022 Feb 09, 2023	BUY	$67.18 - $84.11 $4.87 Million - $6.1 Million	72,467 Added 70.78%	174,846 $14 Million
Q3 2022 Oct 18, 2024	SELL	$66.18 - $82.86 $249,763 - $312,713	-3,774 Reduced 3.56%	102,379 $6.82 Million
Q3 2022 Nov 10, 2022	BUY	$66.18 - $82.86 $6.1 Million - $7.64 Million	92,163 Added 902.14%	102,379 $6.82 Million
Q2 2022 Aug 10, 2022	BUY	$66.18 - $83.18 $676,094 - $849,766	10,216 New	10,216 $776,000

Others Institutions Holding INCY

# of Institutions

733

Shares Held

202M

Call Options Held

516K

Put Options Held

265K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $18.8B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.

Account

Intech Investment Management LLC Incyte Corp Transaction History